Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome

Clinical trial NCT02342184 · COMPLETED

Trial details

NCT number: NCT02342184
Sponsor: Japan Blood Products Organization
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Guillain-Barré Syndrome

Start date: 2014-08-01
Primary completion: 2015-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.